Back

A mechanistic framework for interpreting blood-stage malaria vaccine efficacy

Wood, J. R.; Challenger, J.; Churcher, T.; Okell, L.; Ghani, A.

2026-09-29 infectious diseases
10.64898/2026.09.28.26363670 medRxiv
Show abstract

Blood-stage vaccines (BSVs) against malaria offer a promising avenue for reducing parasite burden and transmission, yet their efficacy is challenging to interpret across different trial phases. In this study we develop a simple mechanistic within-host mathematical model of Plasmodium falciparum asexual parasitaemia. We fit this model to individual-level data from the phase I/IIa RH5.1 trial and estimate the relationship between vaccine efficacy and RH5 antibody titres, enabling the quantitative prediction of vaccine-impact on public health outcomes. We show that small reductions in erythrocyte invasion rate can lead to substantial decreases in probability of exceeding parasitaemia thresholds and transmission potential. Our framework provides a flexible, biologically motivated method for interpreting early-phase trial data and can inform future trial design, vaccine evaluation and integration into broader malaria control strategies.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.